... of allogeneichematopoieticstemcelltransplantation (allo-HSCT) ...and cell surface recognition molecules by host cells and thereby enhancing the recognition of host minor or ...
... before transplantation. The emergence of hematopoietic complications after SOT requires specific treatment by hematologists, and a proportion of patients may be candidates for allogeneic ...
... that allogeneichematopoieticstemcelltransplantation (HSCT) might possibly serve to consolidate the response to initial ...for stemcelltransplantation ...
... after allogeneichematopoieticstemcelltransplantation by donor lymphocyte infusion and STI-571 Donor lymphocyte infusion (DLI) has become standard therapy for relapse after ...
... Renal cell carcinoma (RCC) is particularly sensitive to immune ...after hematopoieticstemcelltransplantation (HSCT), in particular the 14 bp insertion/deletion polymorphism in the 3 ...
... after AllogeneicHematopoieticStemCellTransplantation for Childhood Acute Leukemia: A Leucemie de l’Enfant et de L’Adolescent Study Sandrine Visentin, Pascal Auquier, Yves Bertrand, ...
... · Allogeneichematopoieticstemcelltransplantation Introduction L ’allogreffe de cellules souches hématopoïétiques (ACSH) constitue un traitement curatif de différentes pathologies ...
... received transplantation in CR2, a Karnofsky performance score of 90, diagnosed with acute myeloid leukemia, received transplantation from a matched unrelated donor (MUD) in 2011, and both recipient and ...
... performing allogeneichematopoieticstemcelltransplantation (HSCT) in patients for whom conventional myeloablative allogeneic HSCT would have been associ- ated with ...
... P. Saussoy 1 , J. Libouton 1 , H. Antoine-Poirel 1 1 Cliniques Universitaires Saint-Luc, Brussels, 2 Centre Hospitalier de Luxembourg, Luxembourg A 19-year old woman was diagnosed with acute biphenotypic leukemia. ...
... Background: Allogeneichematopoieticstemcelltransplantation (HSCT) is a curative treat- ment option in both adult and pediatric patients with malignant and non-malignant hemato- ...
... of allogeneichematopoieticstemcelltransplantation (HSCT) 1;2 ...donor stem cells that are primed by histocompatibility differences between donors and recipients and activated ...
... Recent evidence implicates a preparative regi- men-related cytokine storm in the pathogenesis of acute GVHD following hematopoieticstemcelltransplantation. 44 Therefore, delaying the ...
... of stem cells (particularly true for autologous transplants since 1993 in our study) and a larger number of autologous transplants relative to the number of allogeneic ...
... after allogeneichematopoieticcelltransplantation (HCT) has remained unclear thus ...given allogeneic hemato- poietic stem cells after either nonmyeloablative (n ¼ 176) or ...
... A number of other factors may contribute to these differences. Epo levels inappropriately low for the degree of anemia are observed after amphotericin B administration (Lin et al. 1990), but this has not been a clear ...